Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
self-administration
Pharma
Roche's Enspryng muscles in on Tepezza's TED turf
Some six years after scoring an initial FDA nod, Roche’s IL-6 receptor inhibitor Enspryng is muscling up to Amgen's Tepezza in a key eye disease arena.
Fraiser Kansteiner
Oct 16, 2026 9:26am
Vertex taps Halozyme in $15M upfront biologics drug delivery deal
Apr 7, 2026 10:17am
AZ's FluMist wins FDA nod as first self-administered flu vaccine
Sep 20, 2024 3:24pm
CSL asks autoimmune patients what they want from therapies
Jan 16, 2024 11:14am
Phillips-Medisize creates low-waste digital drug delivery device
Jun 1, 2021 8:15am
Lilly taps Arecor to develop self-administration formulation
May 24, 2021 12:20pm
